| Course | MPH 560 Applied Biostatistics for Public Health |
|---|---|
| Module | Module 8 |
| Paper type | Statistical appraisal paper |
| Length | About 1,086 words, 6 pages |
| Format | APA 7 student paper |
| School | Aspen University |
| Program | Master of Public Health |
| Updated | September 2026 |
Free sample paper for MPH 560 Module 8
Reading the Numbers: A Statistical Appraisal of the Diabetes Prevention Program Trial
Student Name
Master of Public Health Program, Aspen University
MPH 560: Applied Biostatistics for Public Health
Instructor Name
Month Day, Year
Reading the Numbers: A Statistical Appraisal of the Diabetes Prevention Program Trial
Public health professionals must read research critically, judging whether statistical methods are appropriate and results are interpreted correctly. This final paper applies the course's concepts to a landmark study: the Diabetes Prevention Program trial, which asked whether intensive lifestyle change or the drug metformin could delay or stop progression to type 2 diabetes among people with raised blood sugar. The appraisal follows the study from design through results and asks what its numbers mean.
The Study Design
The trial randomly assigned 3,234 adults whose fasting and two-hour glucose results were above normal but below the diabetes range to intensive lifestyle intervention, metformin or placebo, and followed them for an average of 2.8 years. The lifestyle goals were at least 7% weight loss and at least 150 minutes of physical activity a week (Diabetes Prevention Program Research Group, 2002). Randomization balances known and unknown confounders between groups, which allows differences in outcomes to be attributed to the interventions.
Sample Size and Power
Trials plan sample size so they have adequate power to detect a meaningful difference. The trial's large sample gave it high power, and it was stopped early when an independent monitoring board found that the benefits were clear. Early stopping for benefit can slightly overstate effects, a point readers should keep in mind. Readers should also check whether the article reports how the sample size was calculated and what effect the study was designed to detect.
Key Results
The table gathers the headline figures from the published report.
| Measure | Placebo | Metformin | Lifestyle |
|---|---|---|---|
| Diabetes incidence per 100 person-years | 11.0 | 7.8 | 4.8 |
| Relative reduction vs placebo | Reference | 31% | 58% |
| Number needed to treat for 3 years to prevent 1 case | About 14 | About 7 |
Incidence Rates
Results were reported as incidence per 100 person-years, which accounts for different lengths of follow-up among participants. An incidence of 11.0 in the placebo group means about 11 new cases for every 100 people followed for one year. Rates allow fair comparison when follow-up varies.
Relative and Absolute Effects
The lifestyle intervention reduced incidence by 58% relative to placebo, and metformin by 31%. Relative reductions describe the proportional effect, but absolute measures show the practical benefit. The number needed to treat, about 7 for lifestyle over three years, means that about seven people would need to complete the program to prevent one case of diabetes. Both relative and absolute measures should be reported. Metformin's number needed to treat, about 14, is roughly twice that of lifestyle change, which reflects its smaller relative effect.
Confidence Intervals
The article reported confidence intervals for the reductions, which were well away from zero, indicating precise estimates. Reporting intervals rather than relying only on P values allows readers to judge both the size and precision of effects (Gardner & Altman, 1986).
Intention to Treat
The main analysis compared groups as randomized, regardless of how well participants adhered, an intention-to-treat approach. This preserves the benefits of randomization and gives a realistic estimate of what happens when an intervention is offered. Per-protocol analyses of only adherent participants may overstate effects.
Interpreting P Values Correctly
The very small P values show that results as extreme would be highly unlikely if the interventions had no effect. The P value, though, carries no information about how large or clinically meaningful the benefit is; that comes from the incidence rates, relative reductions and number needed to treat (Wasserstein & Lazar, 2016). The trial's conclusions rest on effect sizes and design, not on significance alone.
Subgroups and Multiple Comparisons
The article examined whether effects differed by age, sex, race and ethnicity and body mass index. Subgroup findings are more prone to chance because of smaller numbers and multiple comparisons. Readers should look for pre-specified subgroups, tests of interaction rather than separate P values in each subgroup, and consistency with other evidence (Greenland et al., 2016).
Generalizability
Participants were volunteers at clinical centers with intensive, individually delivered coaching, so results may not transfer directly to community settings with less support. Later community programs have produced smaller average weight loss. This is a question of external validity, not of the trial's internal statistical soundness.
A Checklist for Reading Statistics
When reading any public health article, ask: Was the design appropriate? How was the sample chosen and how large was it? Were the right tests used for the data types? Are effects reported with confidence intervals? Are both relative and absolute measures given? Were many comparisons made? Do the conclusions match the evidence?
Baseline Comparability
The article presented baseline characteristics by group, showing similar ages, body mass index and glucose levels across arms. Such tables let readers check that randomization produced comparable groups; statistical tests of baseline differences are not needed, since any differences arose by chance.
Missing Data and Follow-Up
High follow-up rates strengthen confidence in results. Readers should check how many participants completed the study and how missing outcomes were handled, since losses that differ between groups can bias estimates.
Secondary Outcomes
The article also reported weight loss and physical activity, which help explain the results: the lifestyle group lost more weight and was more active. Secondary outcomes should be interpreted cautiously because they are often numerous and less rigorously planned than the primary outcome.
Why This Trial Matters for Public Health
The trial's results led to national programs offering lifestyle change for people with prediabetes. Understanding its statistics, especially the difference between the relative reduction and the number needed to treat, helps planners estimate how many cases a program might prevent and at what cost.
Limits of the Appraisal
This appraisal relied on the published article; a full appraisal might also review the protocol, statistical analysis plan and supplementary tables. Readers should look for these documents when evaluating major trials.
Applying the Checklist to This Trial
Applied to this trial, the checklist gives a favorable picture: a randomized design, a large sample, appropriate rates and tests, intervals reported, relative and absolute effects given and a clear primary outcome. The main cautions concern early stopping and generalizability to community settings.
Conclusion
The Diabetes Prevention Program trial illustrates sound statistical practice: randomization, adequate power, rates that account for follow-up, relative and absolute effects with confidence intervals and intention-to-treat analysis. Its 58% reduction in diabetes incidence with lifestyle change, and a number needed to treat of about 7, remain among the most important findings in prevention. Reading such studies critically, with the tools from this course, allows public health professionals to use evidence well.
References
Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403. https://doi.org/10.1056/NEJMoa012512
Gardner, M. J., & Altman, D. G. (1986). Confidence intervals rather than P values: Estimation rather than hypothesis testing. BMJ, 292(6522), 746-750. https://doi.org/10.1136/bmj.292.6522.746
Greenland, S., Senn, S. J., Rothman, K. J., Carlin, J. B., Poole, C., Goodman, S. N., & Altman, D. G. (2016). Statistical tests, P values, confidence intervals, and power: A guide to misinterpretations. European Journal of Epidemiology, 31(4), 337-350. https://doi.org/10.1007/s10654-016-0149-3
Wasserstein, R. L., & Lazar, N. A. (2016). The ASA statement on p-values: Context, process, and purpose. The American Statistician, 70(2), 129-133. https://doi.org/10.1080/00031305.2016.1154108
Reading the MPH 560 Module 8 assignment instructions
The MPH 560 catalog entry closes with biostatistics as used in peer-reviewed public health publications, and since the closing module's task is not public, this sample appraises a real trial. Appraisal assignments usually ask you to identify a study's design and statistical methods, judge whether they fit, interpret the main results and note limitations. Choose a well-known study with accessible data. Describe the design before the numbers. Explain each statistic in plain terms. Report both relative and absolute effects. Discuss subgroups and multiple comparisons. Separate internal validity from generalizability. Note where the article reports its sample size calculation. Link each statistic to the question it answers.
How the MPH 560 Module 8 example is put together
Eighteen headed parts carry this appraisal, and its four-column table lists incidence, relative reductions and numbers needed to treat. It moves from design and power to the table, then explains rates, relative and absolute effects, intervals, intention to treat, P values, subgroups and generalizability, and gives a reading checklist. Baseline comparability, missing data, secondary outcomes, why the trial matters for planners, limits of the appraisal and the checklist applied to this trial follow. A side note explains that design comes first because it determines what the statistics can mean. The paper closes on reading studies with the course's tools. Every figure in the table is taken from the published trial report.
Reading the MPH 560 Module 8 grading rubric
Appraisal papers are judged on accurate description of design and methods, correct interpretation of results, balanced discussion of strengths and limitations and a clear link to practice. This appraisal cites the trial report, a classic article on confidence intervals, a guide to misinterpretations and the American Statistical Association's statement, all in APA style. Figures in the table match the published article. Absolute and relative effects are both explained. Early stopping and generalizability are flagged. Instructors value appraisals that teach a reusable method, which the checklist provides. A clear explanation of why incidence is expressed per 100 person-years, and why intention to treat preserves randomization, shows command of trial statistics. The reading checklist offers a tool the grader can see you would use again.
Common MPH 560 Module 8 mistakes, and how to avoid them
Students often summarize a study's conclusions without examining its methods, or quote relative reductions without absolute effects. Others treat subgroup findings as definitive. Describe design first. Explain each statistic. Give the number needed to treat where possible. Treat subgroups cautiously. If you are choosing a study to appraise, a tutor can suggest trials with clear reporting and accessible full texts. Close with whether you would change practice based on the study and why. Quote figures exactly as published and cite the page or table if your instructor asks. Explain what early stopping means for effect size. Keep your own opinion separate from the authors' conclusions until the final paragraph.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More MPH 560 and Master of Public Health sample papers
- MPH 560 Module 1: Descriptive Statistics
- MPH 560 Module 2: Probability in Public Health
- MPH 560 Module 3: Sampling and Confidence Intervals
- MPH 560 Module 4: Hypothesis Testing and P Values
- MPH 560 Module 5: Comparing Groups
- MPH 560 Module 6: Nonparametric Tests
- MPH 560 Module 7: Correlation and Regression
- MPH 510 Module 4: Outbreak Investigation
- MPH 520 Module 2: Hazard Vulnerability Analysis
- MPH 501 Module 6: Costs and Benefits of a Public Health Program
- MPH 503 Module 3: Regulation and Rulemaking
MPH 560 Module 8 questions, answered
What does MPH 560 Module 8 usually ask for?
Aspen's MPH 560 covers biostatistics in peer-reviewed public health publications, so appraising the statistics in a published study is a typical final assignment. Confirm with your classroom prompt.
What is the number needed to treat?
The number of people who must receive an intervention for a given time to prevent one additional bad outcome.
What is an intention-to-treat analysis?
Comparing participants in the groups to which they were randomized, regardless of adherence.
Where can I find a free MPH 560 Module 8 sample paper?
The trial appraisal is here in full, with a table of incidence rates, relative reductions and numbers needed to treat.
What should you check when reading statistics in MPH 560 Module 8?
Design, sample size and power, whether tests fit the data, effects with confidence intervals, relative and absolute measures, multiple comparisons and whether conclusions match the evidence.